DUBLIN, Feb. 29, 2024 /PRNewswire/ — The “Home Diagnostics Markets. Strategies and Trends. Forecasts by Application by Channel by Technology and by Country. With Market Analysis and Executive Guides. 2023 to 2027” report has been added to ResearchAndMarkets.com’s offering.
Genetic DTC testing led the way. Now diagnostic testing is moving directly to the consumer. New sampling technology, and rapid and multiplex tests have changed the picture of how and where testing is done. And the COVID-19 situation will lead the charge. This report explores the outlook for all manner of At Home Diagnostics. Find out where the action is and learn about the players.
Exciting technical developments especially in the seesaw between PCR and immunoassay, hold the promise of a dynamic, growing and evolving world market that holds the promise of diagnostics taking the lead in infectious disease eradication. Even CRISPR diagnostics are now coming into play.
The report has hundreds of pages of information including a complete list of Current United States Medicare Fee Payment Schedules to help sharpen your pricing. The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.
Scope of the Report
Global Market Size
- Home Diagnostics Global Market Size Country
- Home Diagnostics Global Market Size Application
- Home Diagnostics Global Market Size Channel
- Home Diagnostics Global Market Size Technology
Global Market Application
- Respiratory Market
- STD Market
- UTI Market
- Pregnancy Market
- Ovulation Market
- DNA Market
Global Market Channel
- Store Market
- Online Market
- Other Channel Market
Global Market Technology
- Immunoassay Market
- Chemistry Market
- Nucleic Acid Market
Key Topics Covered:
1 Market Guides
1.1 Situation Analysis
1.2 Guide Executives Marketing Staff
1.3 Guide Investment Analysts Management Consultants
2 Introduction Market Definition
2.1 What Home Diagnostics?
2.2 Home Testing – quiet revolution diagnostics
2.3 Self Send House – knew?
2.3.1 Self
2.3.2 Send
2.3.3 In-House
2.4 Market Definition
2.4.1 Retail Wholesale
2.5 Application Segments
2.5.1 Channel Segments
2.5.2 Technology Segments
2.5.3 Currency
2.5.4 Years
2.6 Methodology
2.7 Perspective: Healthcare the Industry
2.7.1 Global Healthcare Spending
2.7.2 Spending Diagnostics
2.7.3 Important Role of Insurance Diagnostics
3 Industry Overview
3.1 Industry Participants
3.1.1 Supplier
3.1.2 Independent specialized/esoteric
3.1.3 Independent national/regional
3.1.4 Independent analytical
3.1.5 Public National/regional
3.1.6 Hospital
3.1.7 Physician
3.1.8 Pharmacies
3.1.9 Audit body
3.2 Diagnostic Market Segments
3.2.1 Traditional Market Segmentation
3.2.2 Laboratory Focus Segmentation
3.2.3 Segmenting Home Diagnostics Market
3.3 Industry Structure
3.3.1 Hospital Testing Share
3.3.2 Economies Scale
3.3.3 Hospital Central
3.3.4 Physician Office Lab’s
3.3.4.1 Problem with POLS
3.3.5 Physician’s Home Diagnostics
3.3.6 Pharmacies Home Diagnostics
3.3.6.1 Diagnostic Plight Pharmacies – Trying good
3.3.6.2 Theranos Legacy
4 Market Trends
4.1 Factors Driving Growth
4.1.1 Privacy Anonymity
4.1.2 Internet Effect
4.1.3 Rapid Result
4.1.4 Wellness Movement
4.1.5 COVID-19 Impact
4.2 Factors Limiting Growth
4.2.1 Trust Factor
4.2.2 Infectious Disease Declining But..
4.2.3 Wellness Hurts
4.2.4 Economic Growth improves Living Standards
4.3 Diagnostic Technology Development
4.3.1 Multiplex Paradigm Shift
4.3.2 vs. Lateral Flow
4.3.3 Unusual Role
4.3.4 Self Send Competition
4.3.5 Relationship Genetic
4.3.6 Relationship TeleHealth
4.3.7 Sample Collection – Knew?
5 Home Diagnostics Recent Developments
5.1 Recent Developments – Importance How This Section
5.1.1 Importance of These Developments
5.1.2 Use This Section
5.2 Scripps Research, Cue Health to Offer Home Based Test-to-Treat Program
5.3 KSL Pulse Scientific to Distribute Home Molecular Test in Canada
5.4 Juno Diagnostics Offers NIPT With At-Home Sample Collection
5.5 Sherlock Biosciences Adds to Diagnostic Toolkit
5.6 Morgan Health Invests in LetsGetChecked
5.7 Prenetics ColoClear by Circle
5.8 Detect to Roll Out Next-Gen Molecular Instrument
5.9 Diagnostics for the Real World Third-Generation POC Platform
5.10 Labcorp Partnering With Getlabs for Home Collection
5.11 Salignostics Closes Funding Round
5.12 Cue Health Targets DTC Market in 2022
5.13 Grip Molecular Developing Home Respiratory Panel
5.14 Mainz Biomed Developing Home ColoAlert Assay
5.15 MFB Fertility Closes Series A Financing Round
5.16 Continued Demand for SARS-CoV-2 Rapid Tests
5.17 Rapid Covid-19 Test Results Risk Going Uncounted
5.18 FDA Grants EUAs for Direct-to-Consumer Coronavirus Kit
5.19 Researchers Develop 15-Minute PCR System
5.20 Stanford Developing Low-Cost, At-Home, COVID-19 Saliva Test
5.21 Lucira Health Files for $115M IPO
5.22 Spectrum Solutions Gets CE Mark for Saliva Collection Devices
5.23 Sherlock Biosciences Receives Gates Foundation Grant for COVID-19 Self-Test
5.24 LabCorp Receives EUA for OTC COVID-19 Test Home Collection Kit
Profiles Home Diagnostics Companies
- 1DropDiagnostics
- 23andME Inc.
- Abbott Laboratories
- ADT Biotech
- Akonni Biosystems
- Alveo Technologies
- Anitoa
- Antelope Dx
- Applied BioCode
- Atomo Diagnostics
- Aureum Diagnostics
- Aus Diagnostics
- Becton, Dickinson and Company
- Binx Health
- Biocartis
- BioFire Diagnostics (bioMerieux)
- bioMerieux Diagnostics
- Bio-Rad Laboratories, Inc
- Bosch Healthcare Solutions GmbH
- Cepheid (Danaher)
- Cue Health
- Curetis N.V./Curetis GmbH
- DBS Systems
- Detect
- Diagenode Diagnostics
- Diasorin S.p.A.
- Domus Diagnostics
- Ellume
- Everywell
- Genomadix
- Getlabs
- Grip Molecular Technologies
- Healthy.io
- Hologic
- Inflammatix
- Invetech
- Janssen Diagnostics
- Karius
- Laboratory Corporation of America.
- Letsgetchecked
- Lexagene
- Lucira Health
- Luminex Corp (DiaSorin)
- LumiraDx
- Mbio Diagnostics
- Mesa Biotech (Thermo Fisher)
- MFB Fertility
- Mobidiag (Hologic)
- myLabBox
- Mylan
- NanoDx
- Nanomix
- OraSure Technologies
- Oxford Nanopore Technologies
- Panagene
- Prenetics
- Primerdesign (Novacyt)
- Prominex
- Qiagen
- QuantuMDx
- Quest Diagnostics
- QuidelOrtho
- Randox Toxicology
- Roche Molecular Diagnostics
- Salignostics
- Scanwell Health
- SD Biosensor
- Seegene
- Seventh Sense Biosystems
- Siemens Healthineers
- T2 Biosystems
- TestCard
- Thermo Fisher Scientific Inc.
- Thriva
- Visby Medical
- XCR Diagnostics
Appendices
- United States Medicare System: Clinical Laboratory Fees Schedule
- The Most Used IVD Assays
- The Highest Grossing Assays
For more information about this report visit https://www.researchandmarkets.com/r/xy3p0j
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
